Cargando…
Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autism
The RNS System is not approved in patients under 18, although a critical need for novel treatment modalities in this vulnerable population persist. We present two pediatric patients with drug‐resistant epilepsy secondary to Lennox‐Gastaut Syndrome (LGS) and autism spectrum disorder (ASD) treated wit...
Autores principales: | Kwon, Churl‐Su, Schupper, Alexander J., Fields, Madeline C., Marcuse, Lara V., La Vega‐Talbott, Maite, Panov, Fedor, Ghatan, Saadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545608/ https://www.ncbi.nlm.nih.gov/pubmed/32860345 http://dx.doi.org/10.1002/acn3.51173 |
Ejemplares similares
-
Responsive Neurostimulation of the Thalamus for the Treatment of Refractory Epilepsy
por: Roa, Jorge A., et al.
Publicado: (2022) -
Case Report: Responsive Neurostimulation of the Centromedian Thalamic Nucleus for the Detection and Treatment of Seizures in Pediatric Primary Generalized Epilepsy
por: Welch, William P., et al.
Publicado: (2021) -
Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020) -
Centromedian thalamic neuromodulation for the treatment of idiopathic generalized epilepsy
por: Zillgitt, Andrew J., et al.
Publicado: (2022) -
Lennox-Gastaut syndrome: An overview
por: Ramanathan, Ramnath Santhosh, et al.
Publicado: (2010)